Table 3.

Comparative analysis of variables measured for the EG at the initial and final assessments.

Parameter	Measur.	Med	IQR	Min	Max	Sk.	Z	p	r
EPIC-26 (overall urinary difficulties)	B	2	3	1	5	0.4
	A	1	0.5	0	4	1
	A-B	−1	1.5	−4	0	−0.98	3.5	0.0007	0.8
EPIC-26 (incontinence subscale)	B	9	0	6	10	−2.05
	A	6	3	0	9	−1.05
	A-B	−2	3	−9	0	−1.42	3.47	0.0012	0.8
EPIC-26 (irritation/obstruction subscale)	B	2	5	0	10	0.73
	A	1	1.5	0	9	2.57
	A-B	−1	3.5	−9	1	−1.23	3.1	0.0033	0.71
EPIC-26 (vitality or hormonal symptom)	B	1	4	0	7	0.7
	A	0	1	0	3	1.45
	A-B	−1	2.5	−6	0	−1.16	3.11	0.0042	0.71
EPIC-26 (bowel domain)	B	1	0	0	14	2.46
	A	1	1	0	9	2.22
	A-B	0	1	−13	8	−1.21	1.8	0.0908	0.41
EPIC-26 (sexual symptom)	B	22	6	10	25	−1.1
	A	10	1	0	22	0.9
	A-B	−12	9	−23	−2	−0.11	3.83	<0.001	0.88
BDI-II	B	5	8	0	20	0.77
	A	1	2.5	0	12	1.95
	A-B	−4	4	−19	0	−1.56	3.65	0.0012	0.84
myostatin concentration	B	146.02	49.28	99.38	188.62	−0.14
	A	118.25	43.32	63.35	171.53	−0.07
	A-B	−20.83	22.05	−110.39	−0.55	−1.83	3.82	<0.001	0.88

Min: minimum; Max: maximum; Med: median; IQR: interquartile range; Sk: skewness, Z: Z statistic; r: r statistic; p: significance level.